CSL Group has a rich heritage of excellent contribution to human health. Its 90-year history is filled with innovative efforts to produce serum therapies and become a global icon that it is today.
The company has 10,000 employees, majority of which are working in the major facilities located in the US, Switzerland, Germany and Australia. CSL operates in 27 countries around the world.
CSL has become an expert in human plasma. A process of collecting, testing and donating plasma through plasma-derived products has already saved countless of lives. And the company keeps on researching and developing new products that extend the company’s product portfolio. For instance, a great amount of money is poured in developing protein-based drugs that can treat the most serious human illnesses. CSL’s recombination biotechnology has been successful in producing drugs made from plasma.
Among the company’s businesses involved in plasma products are as follows:
· The CSL Behring is a provider of products derived from recombined plasma. The CSL Plasma is one of the largest networks of plasma collection in the world.
· The CSL Biotherapies is a plasma fractionator known in Taiwan, Singapore, Malaysia, Hong Kong, New Zealand and Australia. CSL Biotherapies is also a producer and seller of vitro diagnostic products.
CSL is the largest producer of influenza vaccine in the world. CSL Biotherapies is involved in selling a wide range of vaccines and anti-venoms.
The success of CSL can be traced to its corporate roots – Emil von Behring. Behring was the first recipient of the Nobel Peace Prize in Physiology and Medicine.